跳至主要内容
临床试验/ACTRN12610000857000
ACTRN12610000857000终止2 期

An open label, randomised, controlled pilot study to evaluate the safety and efficacy of aerosolised surfactant in the first hour of life in preterm infants with respiratory distress syndrome (RDS)

School of Women’s and Infants’ Health (SWIH)0 个研究点目标入组 110 人开始时间: 2010年10月14日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
Hours 至 1 Hours(—)
性别
All

入选标准

  • Preterm infants with a gestational age (GA) between 29 w 0 d and 33 w 6 d AND
  • late preterm and term infants with a GA between 34 w 0 d and 39 w 6 d
  • with clinical or radiological signs of RDS requiring FiO2 of 0.22- 0.30 to maintain a peripheral haemoxyglobin saturation of 88-94%.

排除标准

  • cardiorespiratory instability, cardiothoracic malformations, obvious chromosomal aberrations

研究者

发起方
School of Women’s and Infants’ Health (SWIH)

相似试验